Patent · US Active

Humanized anti-CD4 antibody with immunosuppressive properties

US8440806B2 · kind B2 · utility

19Cited by

18References

11Claims

0Family size

Assignee

Biotest AG · DE

Inventors

John Wijdenes · Larnod, FR
Helmut Jonuleit · Ginsheim-Gustavsburg, DE

Key dates

Filing date	Feb 25, 2009
Grant date	May 14, 2013
Priority date	—
Expiry date	Jun 16, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/73
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A humanized antibody derived from mouse monoclonal anti-CD4 antibody B-F5 is able to activate CD25+CD4+ regulatory T cells and is useful for preparing immunosuppressive compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.